In that study, epigenetic modulators were used to eliminate the inhibition in tumor-bearing mice, increasing tumor infiltration of T cells, retarding progression of tumor, and promoting response to PD-L1 checkpoint blockade along with adoptive T cell transfusion. This evidence concerns the gene CD274 and neoplasm.